Antibiotic use in humans and bacterial resistance

Current Opinion in Microbiology

Volumn 2, Issue 5, 1999, Pages 494-498

  Guillemot, Didier ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; DRUG EXPOSURE; NONHUMAN; PRESCRIPTION; REVIEW; RISK ASSESSMENT;

BACTERIA (MICROORGANISMS);

EID: 0032833952     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(99)00006-5     Document Type: Review

References (61)

1. Baquero F, Negri MC, Morosini MI, Blazquez J Antibiotic-selective environments. Clin Infect Dis. 27(suppl 1):1998;5-11.
2. Baquero F Pneumococcal resistance to beta-lactam antibiotics: a global geographic overview. Microb Drug Resist. 1:1995;115-120.
3. Ena J, Lopez-Perezagua MM, Martinez-Peinado C, Cia-Barrio MA, Ruiz-Lopez I Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquinolones. Diagn Microbiol Infect Dis. 30:1998;103-107.
4. Eady EA Bacterial resistance in acne. Dermatology. 196:1998;59-66.
5. Dowell SF, Schwartz B Resistant pneumococci: protecting patients through judicious use of antibiotics. Am Fam Physician. 55:1997;1647-1654. The authors present evidence of the relationship between antibiotic use and penicillin G resistant Streptococcus pneumoniae as well as patient education materials and recommendations for avoiding the use of antibiotics for some URTIs. Also see http://www.cdc.gov/ncidod/dbmd/antibioticresistance.
6. Jones RN Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the AmpC enzymes. Diagn Microbiol Infect Dis. 31:1998;461-466.
7. Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, Mariano N, Marks S, Burns JM, Dominick D, Lim M Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 280:1998;1233-1237. A before and after comparative two year trial showing the effect of a restriction programme of antibiotic use in hospital. A restriction programme focused on a selective class of antibiotic can lead to an increase bacterial resistance to another antibiotic class.
8. Dahms RA, Johnson EM, Statz CL, Lee JT, Dunn DL, Beilman GJ Third-generation cephalosporins and vancomycin as risk factors for postoperative vancomycin-resistant enterococcus infection. Arch Surg. 133:1998;1343-1346.
9. Monnet DL Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control. Infect Control Hospital Epidemiol. 19:1998;552-559. A review pointing out the lack of studies specifically designed to investigate the relationship between MRSA epidemiology and antibiotic use in hospital. This review underlines the need to implement such studies quickly.
10. Fish DN, Piscitelli SC, Danziger LH Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy. 15:1995;279-291.
11. Brennen C, Wagener MM, Muder RR Vancomycin-resistant Enterococcus faecium in a long-term care facility. J Am Geriatr Soc. 46:1998;157-160.
12. Espersen F Resistance to antibiotics used in dermatological practice. Br J Dermatol. 139(suppl 53):1998;4-8.
13. Raad I, Alrahwan A, Rolston K Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis. 26:1998;1182-1187.
14. Chen DK, McGeer A, de Azavedo JC, Low DE Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med. 341:1999;233-239.
15. Cohen R, Bingen E, Varon E, de La Rocque F, Brahimi N, Levy C, Boucherat M, Langue J, Geslin P Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children. Pediatric Infect Dis J. 16:1997;555-560.
16. Guillemot D, Carbon C, Balkau B, Geslin P, Lecoeur H, Vauzelle-Kervroedan F, Bouvenot G, Eschwege E Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA. 279:1998;365-370.
17. Baquero F Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption? J Chemother. 11(suppl 1):1999;35-43.
18. Stewart FM, Antia R, Levin BR, Lipsitch M, Mittler JE The population genetics of antibiotic resistance. II: analytic theory for sustained populations of bacteria in a community of hosts. Theor Popul Biol. 53:1998;152-165. Recent developments in mathematical models for the dynamics of antimicrobial resistance incorporating the effects of natural selection within untreated hosts, colonisation by bacteria from the environment, and the rapid increase of resistant bacteria in hosts who receive antibiotics.
19. Austin DJ, Kristinsson KG, Anderson RM The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci USA. 96:1999;1152-1156. Using population genetic methods and epidemiological observations, the influence of the selective pressure imposed by the volume of drug use on temporal changes in drug resistance is reported. The results highlight the need for early intervention once resistance is detected.
20. Bonhoeffer S, Lipsitch M, Levin BR Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci USA. 94:1997;12106-12111.
21. Levin BR, Lipsitch M, Perrot V, Schrag S, Antia R, Simonsen L, Walker NM, Stewart FM The population genetics of antibiotic resistance. Clin Infect Dis. 24(suppl 1):1997;9-16.
22. Sebille V, Valleron AJ A computer simulation model for the spread of nosocomial infections caused by multidrug-resistant pathogens. Comput Biomed Res. 30:1997;307-322.
23. Witte W Medical consequences of antibiotic use in agriculture. Science. 279:1998;996-997.
24. Okeke IN, Lamikanra A, Edelman R Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis. 5:1999;18-27. A review describing factors associated with antibiotic resistance in developing tropical countries.
25. Guillemot D, Carbon C, Vauzelle-Kervroedan F, Balkau B, Maison P, Bouvenot G, Eschwege E Inappropriateness and variability of antibiotic prescription among French office-based physicians. J Clin Epidemiol. 51:1998;61-68.
26. Guillemot D, Maison P, Carbon C, Balkau B, Vauzelle-Kervroedan F, Sermet C, Bouvenot G, Eschwege E Trends in antimicrobial drug use in the community - France, 1981-1992. J Infect Dis. 177:1998;492-497.
27. McCaig LF, Hughes JM Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 273:1995;214-219.
28. Davey PG, Bax RP, Newey J, Reeves D, Rutherford D, Slack R, Warren RE, Watt B, Wilson J Growth in the use of antibiotics in the community in England and Scotland in 1980-93. Br Med J. 312:1996;613.
29. Bergus GR, Levy BT, Levy SM, Slager SL, Kiritsy MC Antibiotic use during the first 200 days of life. Arch Fam Med. 5:1996;523-526.
30. Nyquist AC, Gonzales R, Steiner JF, Sande MA Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA. 279:1998;875-877.
31. Gonzales R, Steiner JF, Sande MA Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA. 278:1997;901-904.
32. Little P, Gould C, Williamson I, Warner G, Gantley M, Kinmonth AL Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics. Br Med J. 315:1997;350-352.
33. Mossad SB Treatment of the common cold. Br Med J. 317:1998;33-36.
34. Oeffinger KC, Snell LM, Foster BM, Panico KG, Archer RK Treatment of acute bronchitis in adults. A national survey of family physicians. J Fam Pract. 46:1998;469-475.
35. French National, Observatory for, Drug Use Antibiotic prescription and use in ambulatory patients. Presse Med. 28:1999;343-350.
36. Nafstad P, Hagen JA, Oie L, Magnus P, Jaakkola JJ Day care centers and respiratory health. Pediatrics. 103:1999;753-758.
37. Schrag SJ, Perrot V, Levin BR Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc R Soc Lond B Biol Sci. 264:1997;1287-1291.
38. Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, Huovinen P The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 337:1997;441-446. The main published study on the consequences of a nationwide programme in restriction of antibiotic use in the community.
39. Kristinsson KG Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microb Drug Resist. 3:1997;117-123.
40. Kataja J, Huovinen P, Muotiala A, Vuopio-Varkila J, Efstratiou A, Hallas G, Seppala H Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance. J Infect Dis. 177:1998;786-789.
41. Kataja J, Huovinen P, Skurnik M, Seppala H Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance. Antimicrob Agents Chemother. 43:1999;48-52.
42. Chiew YF, Yeo SF, Hall LM, Livermore DM Can susceptibility to an antimicrobial be restored by halting its use? The case of streptomycin versus Enterobacteriaceae. J Antimicrobial Chemotherapy. 41:1998;247-251.
43. Mebis J, Goossens H, Bruyneel P, Sion JP, Meeus I, Van Droogenbroeck J, Schroyens W, Berneman ZN Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients. Leukemia. 12:1998;1627-1629.
44. Pena C, Pujol M, Ardanuy C, Ricart A, Pallares R, Linares J, Ariza J, Gudiol F Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 42:1998;53-58.
45. Schwartz B Preventing the spread of antimicrobial resistance among bacterial respiratory pathogens in industrialized countries: the case for judicious antimicrobial use. Clin Infect Dis. 28:1999;211-213.
46. Guillemot D, Carbon C Antibiotic use and pneumococcal resistance to penicillin - "The French experience" CMI. 5(suppl 4):1999;38-42.
47. Bax RP, Anderson R, Crew J, Fletcher P, Johnson T, Kaplan E, Knaus B, Kristinsson K, Malek M, Strandberg L Antibiotic resistance - what can we do? Nat Med. 4:1998;545-546.
48. Carbon C, Bax RP Regulating the use of antibiotics in the community. Br Med J. 317:1998;663-665.
49. Yates RR New intervention strategies for reducing antibiotic resistance. Chest. 115:1999;24S-27S.
50. Jarvis WR Epidemiology, appropriateness, and cost of vancomycin use. Clin Infect Dis. 26:1998;1200-1203.
51. Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-intermediate Staphylococcus aureus working group. N Engl J Med. 340:1999;493-501.
52. Evans RS, Pestotnik SL, Classen DC, Clemmer TP, Weaver LK, Orme JF Jr., Lloyd JF, Burke JP A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med. 338:1998;232-238. A computerised anti-infectives-management assessment suggesting that the use of the program led to significant reductions in excess drug dosages, antibiotic-susceptible bacteria, and in the mean number of days of excessive drug dosage.
53. Shojania KG, Yokoe D, Platt R, Fiskio J, Ma'luf N, Bates DW Reducing vancomycin use utilizing a computer guideline: results of a randomized controlled trial. J Am Med Inform Assoc. 5:1998;554-562.
54. Lipsky BA, Baker CA, McDonald LL, Suzuki NT Improving the appropriateness of vancomycin use by sequential interventions. Am J Infect Control. 27:1999;84-91.
55. Natsch S, Conrad C, Hartmeier C, Schmid B Use of amoxicillin-clavulanate and resistance in Escherichia coli over a 4-year period. Infect Control Hosp Epidemiol. 19:1998;653-656.
56. Kolmos HJ, Little P Controversies in management: should general practitioners perform diagnostic tests on patients before prescribing antibiotics? Br Med J. 318:1999;799-802.
57. Dowell SF, Schwartz B, Phillips WR Appropriate use of antibiotics for URIs in children: part I. Otitis media and acute sinusitis. The pediatric URI consensus team. Am Fam Physician. 58:1998;1113-1118.
58. Dowell SF, Schwartz B, Phillips WR Appropriate use of antibiotics for URIs in children: part II. Cough, pharyngitis and the common cold. The pediatric URI consensus team. Am Fam Physician. 58:1998;1335-1342.
59. Mangione-Smith R, McGlynn EA, Elliott MN, Krogstad P, Brook RH The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior. Pediatrics. 103:1999;711-718. A study exploring the extent to which parental previsit expectations and physician perceptions of those expectations are associated with inappropriate antimicrobial prescribing. The authors suggest that physicians have inaccurate perceptions of parent desires for antimicrobials for viral infections.
60. Levin BR, Antia R, Berliner E, Bloland P, Bonhoeffer S, Cohen M, DeRouin T, Fields PI, Jafari H, Jernigan Det al. Resistance to antimicrobial chemotherapy: a prescription for research and action. Am J Med Sci. 315:1998;87-94.
61. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother. 43:1999;1379-1382. The first epidemiological study comparing the risks of emergence of resistance associated with several antibiotics, with a cohort study in hospital. There is an evident difference among antibiotics in the likelihood that their use would allow emergence of resistance.